• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Cardiol Cases . Fulminant myocarditis with complete atrioventricular block after mRNA COVID-19 vaccination: A case report

tetano

Editor, Senior Moderator
J Cardiol Cases


. 2023 Jan 27.
doi: 10.1016/j.jccase.2023.01.004. Online ahead of print.
Fulminant myocarditis with complete atrioventricular block after mRNA COVID-19 vaccination: A case report


Naoaki Onishi[SUP] 1 [/SUP], Yuki Konishi[SUP] 2 [/SUP], Toshiyuki Kaneko[SUP] 2 [/SUP], Naohiro Maekawa[SUP] 2 3 [/SUP], Akihira Suenaga[SUP] 1 [/SUP], Shinnosuke Nomura[SUP] 1 3 [/SUP], Takayasu Kobayashi[SUP] 1 [/SUP], Shokan Kyo[SUP] 1 [/SUP], Marie Okabayashi[SUP] 1 [/SUP], Hirooki Higami[SUP] 1 [/SUP], Maki Oi[SUP] 1 [/SUP], Nobuya Higashitani[SUP] 1 [/SUP], Sayaka Saijo[SUP] 1 [/SUP], Fumiko Nakazeki[SUP] 1 [/SUP], Naofumi Oyamada[SUP] 1 [/SUP], Toshikazu Jinnai[SUP] 1 [/SUP], Tomoko Okuno[SUP] 4 [/SUP], Tomoyuki Shirase[SUP] 4 [/SUP], Kazuaki Kaitani[SUP] 1 [/SUP]



Affiliations

Abstract

A 71-year-old man was transferred urgently to our hospital after collapsing near his home post the first shot of the BNT162b2 coronavirus disease 2019 vaccine (Pfizer-BioNTech, Comirnaty®). Immediately after arrival at our hospital, cardiac arrest due to complete atrioventricular block with no ventricular escaped beats was observed on electrocardiogram. Echocardiography showed preserved left ventricular ejection fraction, however, diffuse severe hypokinesia was revealed after 3 weeks, and he died 3 months after admission because of worsening heart failure. An autopsy examination revealed eosinophilic myocarditis or hypersensitivity myocarditis with extensive fibrosis and widespread myocardial dropout throughout the heart.
Learning objective: 1. Severe myocarditis occurs extremely rarely after mRNA coronavirus disease 2019 (COVID-19) vaccination.2. Myocarditis after mRNA COVID-19 vaccination might cause complete atrioventricular block, followed by a course of decreased left ventricular ejection fraction.3. Histologically, severe myocarditis after mRNA COVID-19 vaccination seems to present as fulminant necrotizing eosinophilic myocarditis or hypersensitivity myocarditis.

Keywords: BNT162b2; Complete atrioventricular block; Coronavirus disease 2019; Eosinophilic myocarditis; Hypersensitivity myocarditis; mRNA.
 
Back
Top Bottom